Reference
Wang M, et al. Benefits and Risks Associated with Low-Dose Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis American Journal of Cardiovascular Drugs : 18 May 2022. Available from: URL: https://doi.org/10.1007/s40256-022-00537-6
Rights and permissions
About this article
Cite this article
Aspirin reduces risk of MACE but increases risk of haemorrhage. Reactions Weekly 1907, 7 (2022). https://doi.org/10.1007/s40278-022-15266-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-15266-1